| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| R&D Expense | $7.4M | +43.2% |
| SG&A Expense | $7.4M | +4.3% |
| Operating Income | -$14.9M | -20.7% |
| Interest Expense | $8K | -83.4% |
| Pre-tax Income | -$14.9M | -20.4% |
| Net Income | -$14.9M | -20.4% |
| EPS (Basic) | -$0.15 | -7.1% |
| EPS (Diluted) | -$0.15 | -7.1% |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | -63.4% |
| Current Assets | $5.8M | -59.5% |
| Total Assets | $5.9M | -59.2% |
| Current Liabilities | $2.9M | +146.4% |
| Total Liabilities | $2.9M | +146.4% |
| Stockholders' Equity | $3.0M | -77.2% |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.9M | -34.9% |
| Investing Cash Flow | -$106K | +0.0% |
| Financing Cash Flow | $200 | -100.0% |